← SynDRA
AMPIROXICAM
SynDRA canonical compound SYN0025569 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | pain relief |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- Modulator
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
Cross-references
Synonyms
- flucam
- CP 65703
- Flucam
- CP-65,703
- CP-65703
- NSC-759807
- Nacyl
- Nasil
- Ampiroxicamum
- 0PV32JZB1J
- NSC 759807
- DTXCID4026474
- CHEBI:31210
- RefChem:557922
- NCGC00164605-01
- Ampiroxicamum [Latin]
- CAS-99464-64-9
- UNII-0PV32JZB1J
- BRN 5184713
- Ampiroxicam [INN:BAN:JAN]
- Flucam (TN)
- MFCD00866079
- Ampiroxicam (Standard)
- AMPIROXICAM [MI]
- AMPIROXICAM [INN]
- AMPIROXICAM [JAN]
- Ampiroxicam (JP18/INN)
- AMPIROXICAM [MART.]
- SCHEMBL49363
- AMPIROXICAM [WHO-DD]
- MLS001424306
- orb1300813
- Ampiroxicam - Bio-X trade mark
- SCHEMBL21357883
- SCHEMBL29385297
- Ampiroxicam, >=98% (HPLC)
- HMS2052J03
- HMS2090I13
Look up AMPIROXICAM in the interactive SynDRA portal →